老年慢性阻塞性肺疾病急性加重期的药物联合雾化吸入治疗

目的观察氨溴索、布地奈德、特布他林联合雾化吸入对老年慢性阻塞性肺疾病（COPD）急性加重期的临床疗效。方法60例老年COPD急性加重期患者分两组：对照组30例，仅给予常规治疗；治疗组30例，常规治疗基础上给予氨溴索15mg、布地奈德1mg、特布他林5mg联合雾化吸入，记录两组患者用药5—7d，临床症状、体征、动脉血气改变及相关副反应如肝肾功能、血糖等情况。结果两组疗效相比有显著性差异（P〈0．05）。结论氨溴索、布地奈德、特布他林联合雾化吸入对老年COPD急性加重期治疗有效，安全性高。

Clinical observation of ambroxol budesonide and terbutaline combinedly atomized inhalation for old patients with acute exacerbation of chronic obstructive pulmonary disease

Objective To evaluate the clinical effect of ambroxol, budesonide and obstructive combinedly atomized inhalation on old patients with acute exacerbation of chronic obstructive pulmonary disease(COPD). Meth-ods 60 old patients with acute exacerbation of COPD were allocated into two groups in random, the control group(n =30) and the treated group(n =30). The control group was received conventinal theray,but the treated group re-ceived combinedly atomized inhalation on basis of conventional therapy. The two groups were treated in five-seven days, and were recorded the changes of clinical symptom, physicak sign, arterial blood gas analysis and the related side effect (for example, liver and renal function, blood sugar, etc). Results There are significant difference be-twcen the two groups in clinical effect (P < 0.05). Conclusion Ambroxol, budesonida and terbutaline combinedly atomized inhalation in the treatment of old patients with acute exacerbation of COPD was effective, little side effect and very safe.